A Maryland pathologist and MedChi past president explains how all-or-nothing contracts, anti-steering clauses and private equity deals inflate costs. He also outlines the federal and state reforms that could restore competition.
Paying membership fees with pretax employer dollars held cost growth to 0.9% a year, but the numbers come with caveats physicians should know before pitching employers.
Prescription abandonment climbs sharply as out-of-pocket costs rise, and prior authorization delays push more patients away. Showing cost and coverage at the point of prescribing could change whether patients ever start therapy.
A critical flaw in the code behind most websites and a breach at one of the nation's largest lab companies landed in the same week. Here's what physicians should check, ask and tell patients now.